: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Fractures

Free Subscription

Articles published in Osteoporos Int
Retrieve available abstracts of 403 articles:
HTML format

Single Articles

December 2025

FLEET JL, Carter B, Cadarette SM, Shariff SZ, et al
Fracture incidence and osteoporosis treatment in Parkinson's disease: a population-based cohort study.
Osteoporos Int. 2025 Dec 10. doi: 10.1007/s00198-025-07802.
PubMed Abstract available

ARCIDIACONO GP, Torres MO, Zanchetta F, Testoni S, et al
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis.
Osteoporos Int. 2025 Dec 10. doi: 10.1007/s00198-025-07799.
PubMed Abstract available

ILOMAKI J, Wood SJ, Tan GSQ, Kim SJ, et al
The effectiveness of bisphosphonates vs denosumab in people with dementia or frailty post hip fracture: a multi-database cohort study.
Osteoporos Int. 2025 Dec 7. doi: 10.1007/s00198-025-07676.
PubMed Abstract available

PARK D, Koh HS, Kim SB, Park JY, et al
Moderate-intensity exercise reduces osteoporotic fracture risk in older women: a dose-response analysis from a nationwide Korean cohort.
Osteoporos Int. 2025 Dec 1. doi: 10.1007/s00198-025-07766.
PubMed Abstract available

LI X, Zhao Y, Cheng L, Yan C, et al
Postoperative osteoporosis therapy and risk of re-fracture in elderly patients with hip fractures: a multicenter retrospective cohort study.
Osteoporos Int. 2025 Dec 1. doi: 10.1007/s00198-025-07757.
PubMed Abstract available

November 2025

GRAUMAM RQ, Silva LVA, Pinheiro MMC, Szejnfeld VL, et al
Loss of muscle and bone mass with increased adiposity and fractures in patients with chronic obstructive pulmonary disease: A 5-year follow-up cohort study.
Osteoporos Int. 2025 Nov 22. doi: 10.1007/s00198-025-07776.
PubMed Abstract available

SPAGNUOLO MC, Shogry FF, Park S, Bakewell N, et al
A scoping review of real-world evidence generation methods to estimate the safety of type 2 diabetes medications on fracture risk.
Osteoporos Int. 2025 Nov 21. doi: 10.1007/s00198-025-07745.
PubMed Abstract available

LUNN EM, Lacount S, Greene LW, Asadipooya K, et al
Management of skeletal-related events and fracture prevention in systemic mastocytosis.
Osteoporos Int. 2025 Nov 20. doi: 10.1007/s00198-025-07726.
PubMed Abstract available

YANG D, Yang J, Wang G
Time to move beyond treatment initiation: implementing risk-stratified therapy in fracture liaison services.
Osteoporos Int. 2025 Nov 19. doi: 10.1007/s00198-025-07777.
PubMed

LESLIE WD, Schousboe JT, Binkley N, Hans D, et al
Complementary effects of trabecular bone score and hip axis length on fracture risk: the Manitoba BMD Registry.
Osteoporos Int. 2025 Nov 18. doi: 10.1007/s00198-025-07754.
PubMed Abstract available

VIJAYASIMHA M
Anabolic-first therapy and planned sequential care in very-high-risk fracture patients: leveraging the REFRA FLS-SEIOMM signal for global implementation.
Osteoporos Int. 2025 Nov 18. doi: 10.1007/s00198-025-07778.
PubMed

ROLLS C, Bastiani O, Antuna M, Fair S, et al
What is the association between physical activity and fracture risk in middle-aged adults (aged 30-60): a systematic review and synthesis without meta-analysis (SWIM).
Osteoporos Int. 2025 Nov 18. doi: 10.1007/s00198-025-07728.
PubMed Abstract available

BOX MW, O'Connor KP, Major J, Puga TB, et al
Anabolic-steroid therapy after geriatric proximal femur fracture: a level I evidence systematic review and meta-analysis of bone density, functional recovery, and safety.
Osteoporos Int. 2025 Nov 17. doi: 10.1007/s00198-025-07762.
PubMed Abstract available

YU P, Tang Z, Chang W, Jia L, et al
Degenerative scoliosis may trigger higher incidence of adjacent vertebral fractures following percutaneous vertebroplasty: a clinical evidence-based biomechanical research.
Osteoporos Int. 2025 Nov 12. doi: 10.1007/s00198-025-07760.
PubMed Abstract available

QI L, Gu Q, Chen B, Yang D, et al
Unmeasured confounding and ascertainment bias in the study of diabetes diagnosis age and fracture risk.
Osteoporos Int. 2025 Nov 12. doi: 10.1007/s00198-025-07767.
PubMed

VISKER VP, Kvist AV, Vestergaard P, van den Bergh JP, et al
Fracture trends in Denmark from 1997 to 2021.
Osteoporos Int. 2025 Nov 6. doi: 10.1007/s00198-025-07746.
PubMed Abstract available

LEWERIN C, Kristjansdottir HL, Entrop J, Smedby KE, et al
Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis-a national registry study of 36,864 Swedish lymphoma patients.
Osteoporos Int. 2025 Nov 4. doi: 10.1007/s00198-025-07733.
PubMed Abstract available

October 2025

SUTTON R, Rogmark C, Fedorowski A, Hamrefors V, et al
The prospective association between high-density lipoprotein (HDL) cholesterol and risk of incident fractures in the general population.
Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07732.
PubMed Abstract available

BUGBIRD AR, Burt LA, Whittier DE, Boyd SK, et al
Localized bone deterioration predicts declining failure load and increased fracture risk.
Osteoporos Int. 2025 Oct 29. doi: 10.1007/s00198-025-07750.
PubMed Abstract available

HOSSEINPOUR M
Clarifying the interpretation of metapgs and cumulative incidence in fracture risk prediction.
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07741.
PubMed

FALK SSI
Author response to letter to the editor to ankle fractures: A pragmatic opportunity for osteoporosis case finding (OSIN-D-25-01889).
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07748.
PubMed

TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
Author's response to letter to editor "Comment on: Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD)-emulation of a ran
Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07739.
PubMed

HUANG CC
Ankle fractures: a pragmatic opportunity for osteoporosis case finding.
Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07743.
PubMed

LO JC, Chandra M, Yang W, Darbinian JA, et al
The association of bone density and hip fracture risk among Asian women.
Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07663.
PubMed Abstract available

ABUDAYEH A, Fishchenko I
Misstated prevalence in fragility-fracture consensus: need for peer-reviewed national data.
Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07742.
PubMed

PHUNG K, Rauch D, Jackowski S, Scharke M, et al
Automated bone age calculation is an independent predictor of vertebral fracture burden in Duchenne muscular dystrophy.
Osteoporos Int. 2025 Oct 21. doi: 10.1007/s00198-025-07681.
PubMed Abstract available

XU Z, Li Y, Song H, Sit RWS, et al
The association of loneliness with bone mineral density, osteoporosis, osteopenia, fall, and sarcopenia among older adults: results from Mr. and Ms. Os (Hong Kong) study.
Osteoporos Int. 2025 Oct 18. doi: 10.1007/s00198-025-07720.
PubMed Abstract available

TAKEGAMI Y, Imaizumi T, Sato K, Osawa Y, et al
Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis.
Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07721.
PubMed Abstract available

KWAK MK, Lee S, Lee JY, Park JW, et al
Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study.
Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07639.
PubMed Abstract available

KAO SW, Huang YC, Chen YC, Cheng MT, et al
Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan.
Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07666.
PubMed Abstract available

SEEFRIED L, Ferrari S, Pall D, Viapiana O, et al
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.
Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07711.
PubMed Abstract available

ADAMI G, Bartezaghi M, Montanari F, Piccinelli A, et al
ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study.
Osteoporos Int. 2025 Oct 13. doi: 10.1007/s00198-025-07722.
PubMed Abstract available

SIMPSON PM, Dobson AJ, Baneshi MR, Mishra GD, et al
Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women's Health.
Osteoporos Int. 2025 Oct 12. doi: 10.1007/s00198-025-07710.
PubMed Abstract available

JANSSENS S, Luyten J, Deschodt M, Sermon A, et al
Clinical and health-economic impact of orthogeriatric care models in Belgium: A population-based data registry study.
Osteoporos Int. 2025;36:1965-1975.
PubMed Abstract available

September 2025

JHA V, Bhadada SK, Pal R, Kharbanda C, et al
Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval.
Osteoporos Int. 2025 Sep 29. doi: 10.1007/s00198-025-07703.
PubMed Abstract available

BJORNEREM A, Khoshkhabari J, Hansen AK, Borgen TT, et al
Adherence to secondary fracture prevention is associated with reduced risk of subsequent fractures.
Osteoporos Int. 2025 Sep 24. doi: 10.1007/s00198-025-07697.
PubMed Abstract available

FALK SSI, Mittlmeier T
Should we consider ankle fractures as osteoporotic fractures?
Osteoporos Int. 2025 Sep 19. doi: 10.1007/s00198-025-07690.
PubMed Abstract available

MONTOYA-GARCIA MJ, Carbonell-Abella C, Garcia MG, Hernandez-Cruz B, et al
Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry.
Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07565.
PubMed Abstract available

LO SW, Yen HK, Huang CC, Lu YC, et al
Incidence, risk factors, prognosis of periprosthetic fractures post hip fracture: unveiling protective role of anti-osteoporotic medication.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07670.
PubMed Abstract available

CRUZ-PRIEGO GA, Araiza-Nava B, Mendez-Sanchez L, Vargas-Chanes D, et al
Predictive capacity of fracture risk assessment tools: overview of systematic reviews.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07642.
PubMed Abstract available

NOOR A, Noor A, Khan HT, Zeb A, et al
From risk marker to life-saver: clinical promise of the albumin hemoglobin index in geriatric hip fractures.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07682.
PubMed

CLARK P, Calo M, Bostico ST, de Pedro AO, et al
Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.
Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07684.
PubMed Abstract available

TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) - emulation of a randomized target trial.
Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07687.
PubMed Abstract available

KONSTANTELOS N, Kim S, Cheung AM, Burden AM, et al
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose.
Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07672.
PubMed Abstract available

KABRA A, Katzman WB, Lane NE, Giangregorio LM, et al
OsteoStrong and bone health: a scoping review.
Osteoporos Int. 2025;36:1521-1534.
PubMed Abstract available

PRASAD TN, Flora SS, Bhadada SK, Yadav U, et al
Anti-resorptive and anabolic therapies improve Falls Risk Assessment Score (FRAS) in postmenopausal women with type 2 diabetes mellitus.
Osteoporos Int. 2025;36:1633-1639.
PubMed Abstract available

August 2025

HIREDESAI AN, Holle AM, Payne CS, Beckett NC, et al
Assessing endocrinology referral rates and osteoporosis directed-care after upper extremity fragility fractures.
Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07665.
PubMed Abstract available

NGUYEN HG, Nguyen DT, Tran TS, Ling SH, et al
Artificial intelligence system for predicting areal bone mineral density from plain X-rays.
Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07634.
PubMed Abstract available

MCCLOSKEY EV, Johansson H, Liu E, Akesson KE, et al
Family history of fracture and fracture risk: a meta-analysis to update the FRAX(R) risk assessment tool.
Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607.
PubMed Abstract available

JIN H, Jin H, Suk KS, Lee BH, et al
Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis.
Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07661.
PubMed Abstract available

OSTERGAARD HK, Budtz CR, Sumrein BO, Madsen MN, et al
Increased all-cause mortality following proximal humerus fractures in Danish adults: a register-based matched cohort study of 93,952 fracture cases and 469,760 controls.
Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07629.
PubMed Abstract available

HARVEY NC, Al-Daghri N, Beaudart C, Brandi ML, et al
Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation.
Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07628.
PubMed Abstract available

WIJEKULASURIYA S, Seymour H, Tarrant S, Balogh ZJ, et al
The impact of direct oral anticoagulants on hip fracture care in Australia and New Zealand: a prospective patient sprint audit.
Osteoporos Int. 2025 Aug 19. doi: 10.1007/s00198-025-07659.
PubMed Abstract available

KOBAYASHI T, Fujii M, Morimoto T
Projected burden of femoral fracture surgeries in Japan through 2035: a nationwide population-based modeling study.
Osteoporos Int. 2025 Aug 15. doi: 10.1007/s00198-025-07655.
PubMed Abstract available

SIAMPANOPOULOU V, Ziogas DC, Lyrarakis G, Anastasopoulou A, et al
Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysis.
Osteoporos Int. 2025 Aug 10. doi: 10.1007/s00198-025-07647.
PubMed Abstract available

BRUCE OL, Haider IT, Cheung AM, Tile L, et al
Femur geometry influences atypical femoral fracture location.
Osteoporos Int. 2025 Aug 8. doi: 10.1007/s00198-025-07654.
PubMed Abstract available

TANG N, Zhang J, Liu X, Yao D, et al
Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis.
Osteoporos Int. 2025 Aug 7. doi: 10.1007/s00198-025-07572.
PubMed Abstract available

LOGGERS SAI, Geraerds AJLM, Joosse P, Willems HC, et al
Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07391.
PubMed

GU Y, Wang Y, Li M, Wang R, et al
Current applications of deep learning in vertebral fracture diagnosis.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07604.
PubMed Abstract available

LORENTZON M, Johansson H, Harvey NC, Liu E, et al
Diminishing returns of fall reduction for hip fracture prevention in older age.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07630.
PubMed Abstract available

CHUNG H, Kim TY, Kim J, Ha YC, et al
Long-term trends of osteoporotic hip fractures in South Korea: analysis of National Health Insurance Data from 2006 to 2022.
Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07537.
PubMed Abstract available

CASSINAT J, Wright V
A cost-saving analysis of pharmacologic management in osteoporotic fracture prevention among postmenopausal women.
Osteoporos Int. 2025 Aug 1. doi: 10.1007/s00198-025-07621.
PubMed Abstract available

July 2025

CHUAN F, Mei M, Liao K, Ye X, et al
DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients.
Osteoporos Int. 2025 Jul 30. doi: 10.1007/s00198-025-07644.
PubMed Abstract available

LEUNG MTY, Lamidi ML, Hartikainen S, Rajamaki B, et al
Incidence of hip fractures in persons with and without Parkinson's disease in Finland: a 15-year longitudinal study.
Osteoporos Int. 2025 Jul 29. doi: 10.1007/s00198-025-07632.
PubMed Abstract available

NIAZI S, Mazloomi M, Ostovar A, Fahimfar N, et al
Fatty acid dietary intakes and blood concentrations in relation to hip fracture risk in adults: a systematic review and meta-analysis of prospective cohort studies.
Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07587.
PubMed Abstract available

LYU FF, Zhang M, Deng YF, Liu Q, et al
Incidence and predictors of residual back pain after percutaneous vertebral augmentation in osteoporotic vertebral compression fracture: a systematic review and meta analysis.
Osteoporos Int. 2025 Jul 23. doi: 10.1007/s00198-025-07609.
PubMed Abstract available

LIU L, Li D
Letter to the editor concerning "The impact of a fracture liaison service with in?hospital anti?osteoporosis treatment on subsequent hip fracture and mortality rates-a single?center retrospective study".
Osteoporos Int. 2025 Jul 17. doi: 10.1007/s00198-025-07433.
PubMed

LUO Z, Feng A, Tyurin A, Cui Q, et al
Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses.
Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07620.
PubMed Abstract available

AWAIS AM, Langrial MZA, Saad M, Choudhry MH, et al
LTE: from early gains to lasting outcomes-expanding ANP-led models for hip fracture recovery.
Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07622.
PubMed

LLOPIS-CARDONA F, Rodriguez-Bernal CL, Hurtado I, Espallargues M, et al
Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain.
Osteoporos Int. 2025 Jul 12. doi: 10.1007/s00198-025-07564.
PubMed Abstract available

ZOULAKIS M, Johansson H, Harvey NC, Axelsson KF, et al
Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study.
Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07588.
PubMed Abstract available

O'HARE B, Santaguida P, Azizudin AM, Papaioannou A, et al
The role of physical performance measures in the physiotherapy assessment and management of older adults with osteoporotic vertebral fractures: a narrative review.
Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07606.
PubMed Abstract available

PARK SS, Jeong H, Ahn CH, Park MJ, et al
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study.
Osteoporos Int. 2025 Jul 8. doi: 10.1007/s00198-025-07574.
PubMed Abstract available

XIA L, Chi H, Cao Q
Letter to the editor about "the impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study".
Osteoporos Int. 2025 Jul 7. doi: 10.1007/s00198-025-07432.
PubMed

BENNETT MJ, Center JR, Carter S, Moles R, et al
Implementing pharmacist-led home medicines reviews within fracture liaison services for better post-fracture care: a qualitative study of patient and practitioner experience.
Osteoporos Int. 2025 Jul 1. doi: 10.1007/s00198-025-07589.
PubMed Abstract available

FERRARI S, Akesson KE, Al-Daghri N, Biver E, et al
Bone microstructure and TBS in diabetes: what have we learned? A narrative review.
Osteoporos Int. 2025;36:1115-1128.
PubMed Abstract available

June 2025

BARKER KL, Newman M, Knight R, Hannink E, et al
Exercise rehabilitation with tailored support for exercise adherence for people with vertebral fragility fractures is more effective than standard rehabilitation: the OPTIN randomised controlled trial.
Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07582.
PubMed Abstract available

PARK J, Kim JW, Nam JH, Kim Y, et al
Comparative analysis of osteoporotic versus pathologic fracture in metastatic colorectal cancer patients.
Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07575.
PubMed Abstract available

DEMERS AJ, Fitton LS, McCulley SML, Delgado-Arellanes I, et al
Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up.
Osteoporos Int. 2025 Jun 27. doi: 10.1007/s00198-025-07557.
PubMed Abstract available

ZHAO AY, Chiu A, Agarwal AR, Harris AB, et al
The growing burden of periprosthetic fractures after total hip arthroplasty: identifying overall trends and at-risk groups.
Osteoporos Int. 2025 Jun 26. doi: 10.1007/s00198-025-07583.
PubMed Abstract available

MCLAUGHLIN EC, Giangregorio LM, Adachi JD, Laing AC, et al
Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.
Osteoporos Int. 2025 Jun 25. doi: 10.1007/s00198-025-07435.
PubMed Abstract available

WANG H, Zhao Y, Liu Q, Jiang Z, et al
Global burden of low bone mineral density related fractures in pre- and post-menopausal women from 1990 to 2021, with projections to 2050.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07586.
PubMed Abstract available

LIU M, Li Y
Four-year trajectories of depressive symptoms and subsequent risk of hip fracture: evidence from China Health and Retirement Longitudinal Study.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07573.
PubMed Abstract available

GADGAARD NR, Varnum C, Nelissen R, Vandenbroucke-Grauls C, et al
Temporal trends in socioeconomic inequalities and risk of infection after hip fracture surgery: a nationwide cohort study, 2010-2021.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07576.
PubMed Abstract available

KAMIYA K, Kojima A, Tachiki T, Imai N, et al
Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study.
Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07577.
PubMed Abstract available

TIMON C, Kotze N, Gantley K, Cassar-Gheiti AJ, et al
Benefits of an advanced nurse practitioner led hip fracture clinic in an Irish Orthopaedic Trauma Service.
Osteoporos Int. 2025 Jun 18. doi: 10.1007/s00198-025-07554.
PubMed Abstract available

DING Q, Zhou B, Leung J, Kwok T, et al
Global trends in burden of fractures, low bone mineral density, and high body mass index from 1990 to 2021, an age-period-cohort analysis.
Osteoporos Int. 2025 Jun 17. doi: 10.1007/s00198-025-07570.
PubMed Abstract available

MITSUTAKE S, Lystad RP, Okuba T, Long JC, et al
Effect of hospital-acquired complications on hospital length of stay and cost for older adults after a hip fracture in New South Wales, Australia.
Osteoporos Int. 2025 Jun 16. doi: 10.1007/s00198-025-07536.
PubMed Abstract available

CUNNINGHAM C, Linehan P, Kilkenny F, Duffy J, et al
Patient education following vertebral fragility fracture: a scoping review.
Osteoporos Int. 2025 Jun 16. doi: 10.1007/s00198-025-07545.
PubMed Abstract available

CARTER C, Guerra S, Clothier L, Barlow S, et al
Rehabilitation after pelvic fragility fracture in older adults: a scoping review.
Osteoporos Int. 2025 Jun 16. doi: 10.1007/s00198-025-07552.
PubMed Abstract available

MARSELOU E, Kelekis A, Dimitriadis Z, Koumantakis GA, et al
Risk factors for refracture or new vertebral compression fractures after percutaneous vertebroplasty: a systematic review and meta-analysis.
Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07523.
PubMed Abstract available

SHOGRY FF, Hayes KN, Kim S, Burden AM, et al
The rise and fall of raloxifene use for osteoporosis, 1999-2022.
Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07544.
PubMed Abstract available

CHOI YH, Wong PY, Fong MK, Chau WW, et al
A potential novel predictor of 1-year mortality in elderly hip fracture patients-albumin haemoglobin index.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07566.
PubMed Abstract available

HUANG CF, Ho CJ, Lin SY, Hwang JS, et al
Asia-Pacific consensus for the management of osteoporosis in men.
Osteoporos Int. 2025 Jun 4. doi: 10.1007/s00198-025-07559.
PubMed Abstract available

CHAKHTOURA M, Akl E, Arabi A, Ahmadieh H, et al
The Lebanese GRADE-based vitamin D guidelines: a paradigm for the MENA region.
Osteoporos Int. 2025;36:937-950.
PubMed Abstract available

May 2025

RIPPL M, Grupp P, Martini S, Muller K, et al
Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk.
Osteoporos Int. 2025 May 30. doi: 10.1007/s00198-025-07540.
PubMed Abstract available

MASHARAWI Y, Lerner A, Weisman A
Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526.
PubMed Abstract available

CHENG R, Zhang L
Case report on possible causes of severe osteoporosis: diffuse panbronchiolitis.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07532.
PubMed Abstract available

GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
Author response to: among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2025 May 23. doi: 10.1007/s00198-025-07520.
PubMed

TAVANO FT, Silva ARB, Castro CHM, de Medeiros Pinheiro M, et al
Secular trend of humeral fractures incidence rates in patients >/= 50 years requiring hospitalization: a retrospective analysis of the public health system data in Brazil from 2004 to 2013.
Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07528.
PubMed Abstract available

MONEGAL A, Carrasco JL, Peris P, Frade-Sosa B, et al
Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation.
Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07525.
PubMed Abstract available

UM YJ, Cho IY, Koo HY, Park YM, et al
Intellectual disabilities and risk of fractures: A population-based cohort study.
Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07519.
PubMed Abstract available

PRAVEEN AD, Jha D, Baker A, Fleps I, et al
Comparison of the time-dependent discriminatory accuracy of femoral strength and bone mineral density for predicting future hip and major osteoporotic fractures: a 16-year follow-up of the AGES-Reykjavik cohort.
Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07503.
PubMed Abstract available

GUO L, Tian F
Author response to: OSIN-D-25-00317, "Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population".
Osteoporos Int. 2025 May 8. doi: 10.1007/s00198-025-07510.
PubMed

LIU E, Liu RY, Moraros J, McCloskey EV, et al
Association between walking and hip fracture in women aged 65 and older: 20-year follow-up from the study of osteoporotic fractures.
Osteoporos Int. 2025 May 7. doi: 10.1007/s00198-025-07508.
PubMed Abstract available

WU Q, Jung J
Precision fracture risk assessment: leveraging genomic and clinical data for personalized care.
Osteoporos Int. 2025 May 6. doi: 10.1007/s00198-025-07517.
PubMed

WANG H, Huang Y
Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population.
Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07509.
PubMed

OUYANG W, Guo G, Zhao C
Comment on: The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07430.
PubMed

April 2025

HOUEL V, Marchasson G, Ramdane N, Philippoteaux C, et al
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis.
Osteoporos Int. 2025 Apr 29. doi: 10.1007/s00198-025-07486.
PubMed Abstract available

QI W, Cui L, Yin X, Yu W, et al
Association between obesity and the prevalence of fractures: a population-based cross-sectional study in China.
Osteoporos Int. 2025 Apr 28. doi: 10.1007/s00198-025-07493.
PubMed Abstract available

ALBRECHT AP, Kistler-Fischbacher M, De Godoi Rezende Costa Molino C, Armbrecht G, et al
Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial.
Osteoporos Int. 2025 Apr 25. doi: 10.1007/s00198-025-07489.
PubMed Abstract available

ADAMS H, Salman L, Drinkwater KJ, Griffin J, et al
Improved radiological diagnosis of osteoporotic vertebral fragility fractures following UK-wide interventions and re-audit-can this be maintained and translated into clinical practice?
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07488.
PubMed Abstract available

CHEN W, March LM, Blyth FM, Alarkawi D, et al
Excess subsequent fracture and mortality risk after ankle fractures: a relative survival analysis of the 45 and Up Study.
Osteoporos Int. 2025 Apr 10. doi: 10.1007/s00198-025-07400.
PubMed Abstract available

RUGGIERO C, Baroni M, Pizzonia M, Giusti A, et al
Pre-fracture functional status and 30-day recovery predict 5-year survival in patients with hip fracture: findings from a prospective real-world study.
Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07427.
PubMed Abstract available

ORHADJE E, Makaram N, Berg K, Hauser B, et al
Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07479.
PubMed Abstract available

BAUMANN AN, Krez AN, Trager RJ, Anaspure OS, et al
Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study.
Osteoporos Int. 2025 Apr 4. doi: 10.1007/s00198-025-07473.
PubMed Abstract available

LIU L, Wang Y, Tan B, Huang P, et al
Association of beta-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07471.
PubMed Abstract available

GATINEAU G, Hind K, Shevroja E, Gonzalez-Rodriguez E, et al
Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness-the osteolaus study.
Osteoporos Int. 2025;36:715-724.
PubMed Abstract available

KHAN AA, AbuAlrob H, Ali DS, Al Kassem Z, et al
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).
Osteoporos Int. 2025;36:673-684.
PubMed Abstract available

March 2025

BHATTOA HP, Vasikaran S, Trifonidi I, Kapoula G, et al
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Internatio
Osteoporos Int. 2025 Mar 28. doi: 10.1007/s00198-025-07422.
PubMed Abstract available

PAN Y, Wan Y, Wang Y, Yu T, et al
Conventional chest computed tomography-based radiomics for predicting the risk of thoracolumbar osteoporotic vertebral fractures.
Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-024-07338.
PubMed Abstract available

BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07452.
PubMed

DOUNGSONG K, Davies J, Ezeofor V, Spencer LH, et al
A cost-consequence analysis of a community-based rehabilitation programme following hip fracture (Fracture in the Elderly Multidisciplinary Rehabilitation-FEMuR III).
Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07459.
PubMed Abstract available

GERDHEM P, Wihlborg A, Bergstrom IB
Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case-control study with a mean 7-year follow-up.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07412.
PubMed Abstract available

CAPPOLA AR, Abraham DS, Kroopnick JM, Huang Y, et al
Sex-specific associations of vitamin D and bone biomarkers with bone density and physical function during recovery from hip fracture: the Baltimore Hip Studies.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07446.
PubMed Abstract available

SOPINA L, Hitz MF, Thygesen LC, Langdahl B, et al
Healthcare and productivity cost of osteoporosis: a Danish register-based quasi-experimental study.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07453.
PubMed Abstract available

PARK JH, Kwon O, Choi JH, Yeom JS, et al
Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07449.
PubMed Abstract available

STARUP-LINDE J, Stoy J, Grinderslev PB, Langdahl B, et al
Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07443.
PubMed Abstract available

WU Q, Jung J
Ensemble-learning approach improves fracture prediction using genomic and phenotypic data.
Osteoporos Int. 2025 Mar 7. doi: 10.1007/s00198-025-07437.
PubMed Abstract available

PARK JW, Kim HY, Kim KM, Kim J, et al
Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022).
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07429.
PubMed Abstract available

BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440.
PubMed Abstract available

MCCARROLL K, Mahon J, Lannon R, Carroll A, et al
Early administration of zoledronic acid after hip fracture.
Osteoporos Int. 2025 Mar 5. doi: 10.1007/s00198-025-07450.
PubMed

LAURSEN N, Solling AS, Harslof T, Langdahl B, et al
Clinical experience with denosumab discontinuation.
Osteoporos Int. 2025;36:435-446.
PubMed Abstract available

February 2025

LIU J, Zhang Y, Yu W, Sun L, et al
TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.
Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07423.
PubMed Abstract available

PETERSEN TG, Rubin KH, Javaid MK, Hermann AP, et al
Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE.
Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07436.
PubMed Abstract available

GUO L, Zhang N, Fan X, Hou X, et al
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population.
Osteoporos Int. 2025 Feb 21. doi: 10.1007/s00198-025-07428.
PubMed Abstract available

KANIS JA, Johansson H, McCloskey EV, Liu E, et al
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.
Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-025-07397.
PubMed Abstract available

PAN S, Yang K, Wang K
Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-024-07329.
PubMed

VAN OOSTWAARD MM, van den Bergh JP, Wyers CE
Author response to the letter to the editor "Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy" (OSIN-D-24-01632).
Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-024-07331.
PubMed

MAKKAR B, Obremskey W, Avidano R, Ott S, et al
The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs).
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401.
PubMed Abstract available

NISSINEN T, Sund R, Suoranta S, Kroger H, et al
Identifying proximal humerus fractures: an algorithmic approach using registers and radiological visit data.
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07414.
PubMed Abstract available

LO JC, Chandra M, Khan MM, Barzilay J, et al
Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-024-07372.
PubMed Abstract available

NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al
Association between vertebral fractures and brain volume: insights from a community cohort study.
Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403.
PubMed Abstract available

January 2025

KAWAMURA K, Murata S, Kitano Y, Mera Y, et al
Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404.
PubMed Abstract available

DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385.
PubMed Abstract available

ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al
Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376.
PubMed Abstract available

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383.
PubMed

CAO D, Cao Z, Liu A
Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374.
PubMed

HOLLTRO HT, Nilsen TIL, Schei B, Tronstad I, et al
Is there an association between birth characteristics and fractures in young adults? The HUNT Study, Norway.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07361.
PubMed Abstract available

AKKAN H, Seyyar GK
Improving readability in AI-generated medical information on fragility fractures: the role of prompt wording on ChatGPT's responses.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07358.
PubMed Abstract available

HUANG Z, Liao TC, Chuang AT, Shao SC, et al
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07381.
PubMed Abstract available

HIRSCH JA, Gilligan C, Chandra RV, Brook A, et al
Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study.
Osteoporos Int. 2025;36:129-140.
PubMed Abstract available

December 2024

RAMSCHUTZ C, Sollmann N, El Husseini M, Kupfer K, et al
Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults.
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07373.
PubMed Abstract available

LIN YC, Chiang PH, Huang JY, Wu WS, et al
Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.
Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356.
PubMed Abstract available

NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al
Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.
Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328.
PubMed Abstract available

BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al
Bilateral femoral neck fractures in pregnancy suggestive of transient osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346.
PubMed Abstract available

YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al
The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study.
Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325.
PubMed Abstract available

CAO D, Chen J, Yu W
Comment on: Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306.
PubMed

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332.
PubMed

VAN OOSTWAARD M, van den Bergh JP, Wyers CE
Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322.
PubMed

RAZA MH, Bhutta ME, Siddique MH
Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330.
PubMed

KIM CH, Kim K, Kim JW
The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314.
PubMed Abstract available

GONDO G, Shin JH, Kunisawa S, Imanaka Y, et al
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07269.
PubMed Abstract available

NARLA RR, Adler RA
Rationale for osteoporosis screening in men.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337.
PubMed Abstract available

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333.
PubMed

GU C, Cui Y
Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327.
PubMed

XU P, Luo J
Comment on "Higher prevalence of thyroid?specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010".
Osteoporos Int. 2024 Dec 9. doi: 10.1007/s00198-024-07334.
PubMed

SALMORAL A, Peris P, Lopez Medina C, Florez H, et al
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309.
PubMed Abstract available

MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al
Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters.
Osteoporos Int. 2024;35:2145-2151.
PubMed Abstract available

TSAI JN, Jordan M, Lee H, Leder BZ, et al
One versus 2 years of alendronate following denosumab: the CARD extension.
Osteoporos Int. 2024;35:2225-2230.
PubMed Abstract available

November 2024

AZAD TD, Wu RJ, Anderson KE, Darden M, et al
Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318.
PubMed Abstract available

ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317.
PubMed Abstract available

TAYLOR-WILLIAMS O, Keen H, Preen DB, Nossent J, et al
First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities.
Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07311.
PubMed Abstract available

DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al
Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service.
Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288.
PubMed Abstract available

SOOPRAMANIEN J, Wakefield A, Marshall L, Nightingale J, et al
Assessing the impact of the 5 Nations Consensus Paper on IV Zolendronate administration post-hip fracture in older patients: experience from a UK teaching hospital.
Osteoporos Int. 2024 Nov 4. doi: 10.1007/s00198-024-07303.
PubMed

October 2024

CAO D, Gu N, Liu A
Comment on: Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248.
PubMed

ZHOU K, Li R, Wang J
Letter to the editor concerning "Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis".
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287.
PubMed

IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284.
PubMed Abstract available

SHARMA M, Beaudart C, Clark P, Fujiwara S, et al
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264.
PubMed Abstract available

TORO LA, Gonzalez FI, Botero S, Garcia HD, et al
Handgrip strength as a predictor of 1?year mortality after hip fracture surgery in the Colombian Andes Mountains.
Osteoporos Int. 2024 Oct 17. doi: 10.1007/s00198-024-07258.
PubMed Abstract available

BARCELOS A, Lopes DG, Mazeda C, Canhao H, et al
Regular physical activity improves physical function and health-related quality of life among middle-aged and older women who suffered a fragility fracture-a population-based cohort.
Osteoporos Int. 2024 Oct 11. doi: 10.1007/s00198-024-07265.
PubMed Abstract available

SAHOTA A, Vass C, Marshall L, Sahota O, et al
Fragility fracture and fear of falling in middle aged adults-a prevalence study.
Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07166.
PubMed

BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251.
PubMed Abstract available

SEO DH, Corr M, Patel S, Lui LY, et al
Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.
Osteoporos Int. 2024;35:1789-1796.
PubMed Abstract available

SHARIFF JRR, Swe KM, Binkley N, Whyte MP, et al
Skeletal fluorosis: an uncommon cause, yet a rescue treatment?
Osteoporos Int. 2024;35:1859-1863.
PubMed Abstract available

September 2024

TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260.
PubMed Abstract available

GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240.
PubMed Abstract available

MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al
Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.
Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255.
PubMed Abstract available

VAN OOSTWAARD MM, Wyers CE, Driessen JHM, van Maren M, et al
The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07180.
PubMed Abstract available

GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al
Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis.
Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250.
PubMed Abstract available

ARMUTCU F, McCloskey E
Insulin resistance, bone health, and fracture risk.
Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227.
PubMed Abstract available

JAIN RK
Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk".
Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242.
PubMed

KHAN AN, Jones RB Jr, Khan N, Yang YX, et al
Trends in hip fracture rates in US male veterans.
Osteoporos Int. 2024 Sep 3. doi: 10.1007/s00198-024-07236.
PubMed Abstract available

LUO Y, Zheng S, Jiang S, Yang G, et al
B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials.
Osteoporos Int. 2024;35:1645-1659.
PubMed Abstract available

MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al
Association between socioeconomic deprivation and bone health status in the UK biobank cohort participants.
Osteoporos Int. 2024;35:1573-1584.
PubMed Abstract available

August 2024

LIN CJ, Liu SJ, Lin KY
Author response to OSIN-D-24-00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201.
PubMed

LI J, Zheng J
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200.
PubMed

FAN Z, Zhao J, Chen J, Hu W, et al
Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study.
Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235.
PubMed Abstract available

MITSUTAKE S, Lystad RP, Long JC, Braithwaite J, et al
Correction: Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.
Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07226.
PubMed

ZHOU Q, Chen J
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social.
Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07186.
PubMed

JAIN RK, Polley E, Weiner M, Iwamaye A, et al
An electronic health record (EHR)-based risk calculator can predict fractures comparably to FRAX: a proof-of-concept study.
Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07221.
PubMed Abstract available

TRAN TS, Bliuc D, Blank RD, Center JR, et al
Fracture risk assessment in the presence of competing risk of death.
Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224.
PubMed Abstract available

MCCARROLL K, Fitzpatrick D, Lannon R
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218.
PubMed

KUMAR S, Gild ML, McDonald MM, Kim AS, et al
Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214.
PubMed

ZENG Y, Yang Y, Wang J, Meng G, et al
The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191.
PubMed Abstract available

GANDHAM A, Gregori G, Johansson L, Larsson BAM, et al
Sarcopenia definitions and their association with injurious falls in older Swedish women from the Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone fractures (SUPERB) study.
Osteoporos Int. 2024 Aug 6. doi: 10.1007/s00198-024-07196.
PubMed Abstract available

HADJI P, Kamali L, Thomasius F, Horas K, et al
Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral co
Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208.
PubMed Abstract available

KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al
Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211.
PubMed Abstract available

July 2024

MITSUTAKE S, Lystad RP, Long JC, Braithwaite J, et al
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.
Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07203.
PubMed Abstract available

TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al
Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawai'i: higher mortality risk among Native Hawaiians and other Pacific Islanders.
Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195.
PubMed Abstract available

MAZEDA C, Azevedo SF, Barcelos A
What the American Society of Anesthesiologists classification scores tell us after a hip fracture?
Osteoporos Int. 2024 Jul 26. doi: 10.1007/s00198-024-07199.
PubMed

LE HV, Van BW, Shahzad H, Teng P, et al
Fracture liaison service-a multidisciplinary approach to osteoporosis management.
Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181.
PubMed Abstract available

SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al
Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures.
Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169.
PubMed Abstract available

JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al
Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.
Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171.
PubMed Abstract available

MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al
Birth weight and birth length affect future fracture risk differently in men and women.
Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172.
PubMed Abstract available

HEUSER L, Schoeneberg C, Rascher K, Lendemans S, et al
Validation of the Geriatrics at Risk Score (GeRi-Score) on 120-day follow-up, the influence of preoperative geriatric visits, and the time to surgery on the outcome of hip fracture patients: an analysis from the Registry for Geriatric Trauma (ATR-DGU)
Osteoporos Int. 2024 Jul 4. doi: 10.1007/s00198-024-07177.
PubMed Abstract available

KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162.
PubMed Abstract available

BENSKY MJ, Adler L, Banon T, Gabay L, et al
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174.
PubMed

PARK SY, Ahn SH, Bae GH, Jang S, et al
Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159.
PubMed Abstract available

KIMURA S, Sunouchi T, Watanabe S, Hoshino Y, et al
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.
Osteoporos Int. 2024 Jul 1. doi: 10.1007/s00198-024-07168.
PubMed Abstract available

June 2024

HESTNES I, Solberg LB, Meyer HE, Sundet M, et al
The hip fracture incidence in the high-risk area Oslo continues to decline.
Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07156.
PubMed Abstract available

HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al
Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133.
PubMed Abstract available

BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al
The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.
Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152.
PubMed Abstract available

MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al
Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries.
Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149.
PubMed Abstract available

ZHAO AY, Ferraro S, Agarwal A, Mikula JD, et al
Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty.
Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07147.
PubMed Abstract available

SO E, Juels C, Scott RT, Sietsema DL, et al
A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association's Own the Bone Database.
Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153.
PubMed Abstract available

MILTON-COLE R, Sheehan KJ
Author response to: OSIN-D-24-00452, "Comment on: Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis".
Osteoporos Int. 2024 Jun 14. doi: 10.1007/s00198-024-07125.
PubMed

WU H, Xiao H
Comment on: Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 Jun 14. doi: 10.1007/s00198-024-07124.
PubMed

XU MZ, Lu K, Ye YW, Xu SM, et al
Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis.
Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142.
PubMed Abstract available

GKANIATSA E, Sandstrom TZ, Rosengren A, Trimpou P, et al
Hip fractures in patients with primary aldosteronism - a Swedish nationwide study.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07132.
PubMed Abstract available

LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al
Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131.
PubMed Abstract available

KUMAR S, Gild ML, McDonald MM, Kim AS, et al
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139.
PubMed Abstract available

CHARATCHAROENWITTHAYA N, Nimitphong H, Wattanachanya L, Songpatanasilp T, et al
Epidemiology of hip fractures in Thailand.
Osteoporos Int. 2024 Jun 4. doi: 10.1007/s00198-024-07140.
PubMed Abstract available

TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al
Developing fracture liaison service framework based on comparative analysis and scoping review.
Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091.
PubMed Abstract available

ZHOU L, Zhou H, Xu H, Sun X, et al
Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
Osteoporos Int. 2024;35:997-1005.
PubMed Abstract available

May 2024

CHANDRASOMA D, Chiu S, Niddrie F, Major G, et al
Should major trauma fractures be part of a fracture liaison service's remit: a cost-benefit estimate.
Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07134.
PubMed Abstract available

PARK YB, Kim M, Nam HC, Jeon JW, et al
Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138.
PubMed Abstract available

MENNEN AHM, Maas M, van Embden D
Letter of rebuttal to 'Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review'.
Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07117.
PubMed

ZHANG Y, Lu M, Wang L
Comment on: imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review.
Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07107.
PubMed

WANG X, Zhao X
Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098.
PubMed

HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094.
PubMed

DAGNELIE PC, Willems PC, Jorgensen NR
Nutritional status as independent prognostic factor of outcome and mortality until five years after hip fracture: a comprehensive prospective study.
Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07088.
PubMed Abstract available

ANSARI H, Jaglal S, Cheung AM, Jain R, et al
Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123.
PubMed Abstract available

TAKAKUBO Y, Miyaji T, Ota D, Takahashi T, et al
Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07116.
PubMed

LIN CJ, Lee YS, Yeh JH, Liu SJ, et al
The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097.
PubMed Abstract available

ALI A, Huszti E, Noordin S, Ali U, et al
Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078.
PubMed Abstract available

FUNAKOSHI Y, Maruyama K, Kato T, Saito I, et al
Association of depressive symptoms with incident fractures: the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT).
Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07106.
PubMed Abstract available

KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al
Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.
Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118.
PubMed Abstract available

XIAO X, Wu Q
Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits.
Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105.
PubMed Abstract available

LIU B, Ng CY, La PBD, Wong P, et al
Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099.
PubMed Abstract available

April 2024

PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
PubMed Abstract available

GOLD DT, Beckett T, Deal C, James AL, et al
Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
PubMed Abstract available

WANG M, Seibel MJ
Secondary fracture prevention in primary care: a narrative review.
Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036.
PubMed Abstract available

AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
PubMed Abstract available

ZUBICK P, Dahlke S
Family/caregiver influence on osteoporosis management for older people: an integrative review.
Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
PubMed Abstract available

WU J, Li J, Yan Z, Yu X, et al
Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010.
Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083.
PubMed Abstract available

XIN Z, Xu H, Zhang X, Samelson EJ, et al
Association of bone fracture with 30-year body mass index (BMI) trajectories: findings from the Framingham Heart Study : Bone fracture and 30-year BMI trajectories.
Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07068.
PubMed Abstract available

CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
PubMed Abstract available

LEMS WF, van den Bergh JP, Geusens P
Follow-up in Fracture Liaisons Services: the involvement of general practitioners and fracture nurses is urgently needed.
Osteoporos Int. 2024 Apr 6. doi: 10.1007/s00198-024-07079.
PubMed

LANE J, Langdahl B, Stone M, Kurth A, et al
Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049.
PubMed Abstract available

GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
PubMed Abstract available

ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
PubMed Abstract available

WHITING PS, Hare K, Krueger D, Borchardt G, et al
Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
PubMed Abstract available

March 2024

KOBAYASHI T, Morimoto T, Mawatari M
Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
PubMed

DANAZUMI MS, Lightbody N, Dermody G
Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis.
Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052.
PubMed Abstract available

CAI Y, Jun G, Zhuang X
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
PubMed Abstract available

LORENTZON M, Litsne H, Axelsson KF
The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
PubMed Abstract available

LI D, Mao SS, Budoff MJ
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
PubMed Abstract available

PLUSKIEWICZ W, Tabor E
The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
PubMed

MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
The yield of routine laboratory examination in osteoporosis evaluation in primary care.
Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
PubMed Abstract available

TAGUCHI A
Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
PubMed

CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al
Physical function trajectory after wrist or lower arm fracture in postmenopausal women: results from the Women's Health Initiative Study.
Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050.
PubMed Abstract available

CLARK P, Cruz-Priego GA, Rascon-Pacheco RA, Bremer A, et al
Incidence of hip fractures in Mexico 2006-2019: increasing numbers but decreasing rates.
Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07045.
PubMed Abstract available

KAY RS, Ho L, Clement ND, Duckworth AD, et al
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study.
Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07039.
PubMed Abstract available

HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
Associations between ultra-distal forearm bone mineral density and incident fracture in women.
Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
PubMed Abstract available

February 2024

LIPPUNER K, Kyuchukova M, Schwab P, Rizzoli R, et al
Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021-reversal of the secular trend?
Osteoporos Int. 2024 Feb 24. doi: 10.1007/s00198-024-07016.
PubMed Abstract available

PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
PubMed Abstract available

SCHENE MR, Willems HC, Driessen JHM, Vranken L, et al
Physical performance and sarcopenia assessment in patients with a recent fracture visiting the Fracture Liaison Service.
Osteoporos Int. 2024 Feb 13. doi: 10.1007/s00198-023-07009.
PubMed Abstract available

XU L, Zhao T, Perry L, Frost SA, et al
Return on investment of fracture liaison services: a systematic review and analysis.
Osteoporos Int. 2024 Feb 1. doi: 10.1007/s00198-024-07027.
PubMed Abstract available

CHATTARIS T, Yang L, Johansson H, Sahni S, et al
Performance of FRAX in older adults with frailty: the Framingham Heart Study.
Osteoporos Int. 2024;35:265-275.
PubMed Abstract available

January 2024

YU W, Guan WM, Hayashi D, Lin Q, et al
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
PubMed Abstract available

CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
PubMed

SMITH TO, Brown O, Baxter MA
Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography.
Osteoporos Int. 2024 Jan 27. doi: 10.1007/s00198-024-07030.
PubMed Abstract available

SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
PubMed Abstract available

BENNETT MJ, Center JR, Perry L
Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
PubMed Abstract available

IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
PubMed Abstract available

JEON S, Yu D, Kim S, Kim SW, et al
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
PubMed Abstract available

CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
PubMed Abstract available

BYUN SE, Kim H, Lee SY, Kim SM, et al
Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
PubMed Abstract available

SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
PubMed Abstract available

VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
PubMed Abstract available

LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
PubMed Abstract available

CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
PubMed Abstract available

MULKERRIN P, O'Shea F, Fitzgerald G
Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
PubMed

BHATTACHARYA S, Nagendra L, Chandran M, Kapoor N, et al
Trabecular bone score in adults with type 1 diabetes: a meta-analysis.
Osteoporos Int. 2024;35:105-115.
PubMed Abstract available

December 2023

YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
PubMed Abstract available

YOO JE, Huh Y, Kim E, Park SH, et al
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
PubMed Abstract available

ANDREASEN C, Dahl C, Solberg LB, Borgen TT, et al
Epidemiology of forearm fractures in women and men in Norway 2008-2019.
Osteoporos Int. 2023 Dec 12. doi: 10.1007/s00198-023-06990.
PubMed Abstract available

ZHOU YF, Wang J, Wang XL, Song SS, et al
A prediction model of elderly hip fracture mortality including preoperative red cell distribution width constructed based on the random survival forest (RSF) and Cox risk ratio regression.
Osteoporos Int. 2023 Dec 7. doi: 10.1007/s00198-023-06988.
PubMed Abstract available

HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
PubMed Abstract available

November 2023

HOU XL, Liu JY, Fan XH, Zhang N, et al
Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China.
Osteoporos Int. 2023 Nov 30. doi: 10.1007/s00198-023-06987.
PubMed

PERIS P, Blasco J, Monegal A, Florez H, et al
Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures.
Osteoporos Int. 2023 Nov 30. doi: 10.1007/s00198-023-06960.
PubMed Abstract available

BUI M, Nijmeijer WS, Hegeman JH, Witteveen A, et al
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery.
Osteoporos Int. 2023 Nov 24. doi: 10.1007/s00198-023-06942.
PubMed Abstract available

BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
PubMed Abstract available

KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
PubMed Abstract available

AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
The incremental risk of fragility fractures in aging men.
Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
PubMed Abstract available

JAVAID MK, Calo M, Wullich S, Mohsin Z, et al
Development, implementation and evaluation of a multinational FLS mentorship programme in Latin America.
Osteoporos Int. 2023;34:1881-1891.
PubMed Abstract available

October 2023

HALL AJ, Clement ND, MacLullich AMJ, White TO, et al
Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: the nationwide data-linked IMPACT Protect study.
Osteoporos Int. 2023 Oct 28. doi: 10.1007/s00198-023-06954.
PubMed Abstract available

HAN S, Kim S, Yeh EJ, Suh HS, et al
Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
PubMed Abstract available

INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
PubMed Abstract available

LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
PubMed Abstract available

MITCHELL DM, Singhal V, Nimmala S, Lauze M, et al
Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults.
Osteoporos Int. 2023 Oct 21. doi: 10.1007/s00198-023-06941.
PubMed Abstract available

KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
PubMed

ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
PubMed Abstract available

MILTON-COLE R, Kazeem K, Gibson A, Guerra S, et al
Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis.
Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06923.
PubMed Abstract available

PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
PubMed Abstract available

REILAND K, Haastert B, Arend W, Kluppelholz B, et al
Epidemiology of distal radius fractures in Germany - incidence rates and trends based on inpatient and outpatient data.
Osteoporos Int. 2023 Oct 11. doi: 10.1007/s00198-023-06904.
PubMed Abstract available

YAN F, Wu L, Lang J, Huang Z, et al
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
PubMed Abstract available

TARALDSEN K, Polhemus A, Engdal M, Jansen CP, et al
Evaluation of mobility recovery after hip fracture: a scoping review of randomized controlled studies.
Osteoporos Int. 2023 Oct 6. doi: 10.1007/s00198-023-06922.
PubMed Abstract available

LI N, van den Bergh JP, Boonen A, Wyers CE, et al
Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
PubMed Abstract available

OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
Osteoporos Int. 2023;34:1799-1804.
PubMed Abstract available

September 2023

MAAS L, Raskin N, van Onna M, Cornelissen D, et al
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
PubMed Abstract available

HUNG WC, Lin YL, Cheng TT, Chin WL, et al
Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
PubMed Abstract available

LIU X, Makaroff KE, Almario CV, Khalil C, et al
Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
PubMed Abstract available

ELWAKIL W, El Gaafary M, El Miedany Y
Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
PubMed Abstract available

FENG JN, Zhang CG, Li BH, Zhan SY, et al
Global burden of hip fracture: The Global Burden of Disease Study.
Osteoporos Int. 2023 Sep 14. doi: 10.1007/s00198-023-06907.
PubMed Abstract available

CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
PubMed Abstract available

LU K, Wu YM, Shi Q, Gong YQ, et al
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
PubMed Abstract available

WANG X, Zhang F, Zhang Y, Zhang J, et al
Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Osteoporos Int. 2023 Sep 11. doi: 10.1007/s00198-023-06908.
PubMed Abstract available

NICOLAES J, Liu Y, Zhao Y, Huang P, et al
External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
PubMed Abstract available

RAUF MA, Kotecha J, Moss K
Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology.
Osteoporos Int. 2023;34:1647-1652.
PubMed Abstract available

August 2023

MOAYYERI A, Warden J, Han S, Suh HS, et al
Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
PubMed Abstract available

BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
PubMed Abstract available

BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
PubMed Abstract available

HONG N, Shin S, Lee S, Rhee Y, et al
Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
PubMed Abstract available

EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
Osteoporos Int. 2023 Aug 18. doi: 10.1007/s00198-023-06887.
PubMed

TURABI RY, Sheehan KJ
Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
PubMed

MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
The importance of structural barriers of osteoporotic hip fracture in the elderly.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
PubMed

KANIS JA, Johansson H, McCloskey EV, Liu E, et al
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
PubMed Abstract available

SKULADOTTIR SS, Hjaltadottir I, Launer L, Cotch MF, et al
Milk intake and hip fracture incidence in community-dwelling old Icelandic adults.
Osteoporos Int. 2023 Aug 10. doi: 10.1007/s00198-023-06883.
PubMed Abstract available

SEO DH, Jeong Y, Cho Y, Kim SH, et al
Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
PubMed Abstract available

DOUSSIERE M, Jesson C, Diep L, Menis J, et al
Clinical and biological parameters associated with fracture recurrence according to fracture liaison service dataset.
Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06868.
PubMed Abstract available

FITZPATRICK D, Lannon R, Laird E, Ward M, et al
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study.
Osteoporos Int. 2023 Aug 2. doi: 10.1007/s00198-023-06867.
PubMed Abstract available

FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
PubMed

ZITTERMANN A, Schmidt A, Haardt J, Kalotai N, et al
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society.
Osteoporos Int. 2023;34:1335-1353.
PubMed Abstract available

July 2023

EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
PubMed Abstract available

THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
PubMed Abstract available

TSAI YL, Wu CH, Li CC, Shih CA, et al
Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients.
Osteoporos Int. 2023 Jul 19. doi: 10.1007/s00198-023-06845.
PubMed Abstract available

SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
PubMed Abstract available

JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
PubMed Abstract available

SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
PubMed Abstract available

June 2023

SCHOUSBOE JT, Binkley N, Leslie WD
Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
PubMed Abstract available

ZHANG X, Yang M, Zhang J, Ye P, et al
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry.
Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06832.
PubMed Abstract available

YEH EJ, Rajkovic-Hooley O, Silvey M, Ambler WS, et al
Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study.
Osteoporos Int. 2023 Jun 19. doi: 10.1007/s00198-023-06822.
PubMed Abstract available

GADGAARD NR, Varnum C, Nelissen RGHH, Vandenbroucke-Grauls C, et al
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study.
Osteoporos Int. 2023 Jun 17. doi: 10.1007/s00198-023-06823.
PubMed Abstract available

HAGINO H, Moriwaki K, Wada T, Osaki M, et al
Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
PubMed Abstract available

HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
Osteoporosis medication adherence tools: a systematic review.
Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
PubMed Abstract available

MENNEN AHM, Blokland AS, Maas M, van Embden D, et al
Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review.
Osteoporos Int. 2023 Jun 7. doi: 10.1007/s00198-023-06812.
PubMed Abstract available

May 2023

LU K, Wu YM, Shi Q, Gong YQ, et al
The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
PubMed Abstract available

CHATTARIS T, Chahal K, Berry SD
Factors besides frailty index affect length of stay in older patients with hip fractures.
Osteoporos Int. 2023 May 29:1-2. doi: 10.1007/s00198-023-06798.
PubMed

GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
Mortality among older adults with osteoporotic vertebral fracture.
Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
PubMed Abstract available

KWON H, Han KD, Kim BS, Moon SJ, et al
Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
PubMed Abstract available

KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
PubMed Abstract available

YANG H, Bai J, Li L, Yang Y, et al
Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
PubMed Abstract available

KONG SH, Kim S, Kim Y, Kim JH, et al
Development and validation of common data model-based fracture prediction model using machine learning algorithm.
Osteoporos Int. 2023 May 17. doi: 10.1007/s00198-023-06787.
PubMed Abstract available

AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
PubMed Abstract available

AVGERINOU C, Petersen I, Clegg A, West RM, et al
Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
PubMed Abstract available

METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
PubMed Abstract available

April 2023

MYUNG SK, Cho H
Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis.
Osteoporos Int. 2023 Apr 29. doi: 10.1007/s00198-023-06761.
PubMed Abstract available

ZEELENBERG ML, Den Hartog D, Panneman MJM, Polinder S, et al
Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study.
Osteoporos Int. 2023 Apr 29. doi: 10.1007/s00198-023-06774.
PubMed Abstract available

RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
PubMed Abstract available

LEE RH, Bain J, Muehlbauer M, Ilkayeva O, et al
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case-control study.
Osteoporos Int. 2023 Apr 26. doi: 10.1007/s00198-023-06763.
PubMed Abstract available

BYUN SE, Lee KJ, Shin WC, Moon NH, et al
The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis.
Osteoporos Int. 2023 Apr 25. doi: 10.1007/s00198-023-06768.
PubMed Abstract available

SOLAIMAN RH, Irfanullah E, Navarro SM, Keil EJ, et al
Rising incidence of stair-related upper extremity fractures among older adults in the United States: a 10-year nationwide analysis.
Osteoporos Int. 2023 Apr 24:1-8. doi: 10.1007/s00198-023-06769.
PubMed Abstract available

BENNETT MJ, Center JR, Perry L
Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
PubMed Abstract available

TSUTSUI T, Fujiwara T, Matsumoto Y, Kimura A, et al
Geriatric nutritional risk index as the prognostic factor in older patients with fragility hip fractures.
Osteoporos Int. 2023 Apr 17. doi: 10.1007/s00198-023-06753.
PubMed Abstract available

PONZANO M, Tibert N, Brien S, Funnell L, et al
Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
PubMed

YANG T, Wu J, Ding X, Zhou B, et al
The association of melatonin use and hip fracture: a matched cohort study.
Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06740.
PubMed Abstract available

ICONARU L, Charles A, Baleanu F, Moreau M, et al
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
PubMed Abstract available

TURABI RY, Wyatt D, Guerra S, O'Connell MDL, et al
Barriers and facilitators of weight bearing after hip fracture surgery among older adults. A scoping review.
Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-023-06735.
PubMed Abstract available

KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
PubMed Abstract available

TANG Y, Zhang L, Ye D, Zhao A, et al
Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
PubMed Abstract available

March 2023

GOEL H, Binkley N, Hans D, Leslie WD, et al
Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
PubMed Abstract available

BAILLET M, Morello R, Vittecoq O, Chavoix C, et al
Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study.
Osteoporos Int. 2023 Mar 24. doi: 10.1007/s00198-023-06701.
PubMed Abstract available

BINKLEY N, Nickel B, Anderson PA
Periprosthetic fractures: an unrecognized osteoporosis crisis.
Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
PubMed Abstract available

BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
Epidemiology of male osteoporosis in Denmark (1996-2018).
Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
PubMed Abstract available

SCHOENEBERG C, Heuser L, Rascher K, Lendemans S, et al
The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture - a development and validation study from the Registry for Geriatric Trauma (ATR-DGU).
Osteoporos Int. 2023 Mar 9. doi: 10.1007/s00198-023-06719.
PubMed Abstract available

EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
PubMed Abstract available

WALSH ME, Cunningham C, Brent L, Savin B, et al
Long-term outcome collection after hip fracture in Ireland: a systematic review of traditional and grey literature.
Osteoporos Int. 2023 Mar 4. doi: 10.1007/s00198-023-06713.
PubMed Abstract available

TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
PubMed Abstract available

HANS D, McDermott M, Huang S, Kim M, et al
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
PubMed Abstract available

NIJMEIJER WS, Voorthuis BJ, Groothuis-Oudshoorn CGM, Wurdemann FS, et al
The prediction of early mortality following hip fracture surgery in patients aged 90 years and older: the Almelo Hip Fracture Score 90 (AHFS(90)).
Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06696.
PubMed Abstract available

February 2023

JUNG SY, Cho EB, Han KD, Jung JH, et al
Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
PubMed Abstract available

HE D, Pan C, Zhao Y, Wei W, et al
Exome-wide screening identifies novel rare risk variants for bone mineral density.
Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
PubMed Abstract available

XIAO X, Wu Q
Ethnic disparities in fracture risk assessment using polygenic scores.
Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
PubMed Abstract available

ABDALBARY M, Chishti E, Shakhashiro M, Mohamed R, et al
Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
Osteoporos Int. 2023 Feb 15. doi: 10.1007/s00198-023-06686.
PubMed Abstract available

ARMSTRONG P, Kuo YF, Cram P, Westra J, et al
National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer's disease/related dementias.
Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06680.
PubMed Abstract available

January 2023

VERDONCK C, Willems R, Borgermans L
Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review.
Osteoporos Int. 2023 Jan 25. doi: 10.1007/s00198-023-06678.
PubMed Abstract available

KHAN MI
Management of bone loss due to endocrine therapy during cancer treatment.
Osteoporos Int. 2023 Jan 19. doi: 10.1007/s00198-023-06672.
PubMed Abstract available

December 2022

NEWSON L, Ball S, Lewis R
Letter to Editor: Our concerns about HRT not having a priority as a treatment for osteoporosis in the NOGG guidelines.
Osteoporos Int. 2022 Dec 28. doi: 10.1007/s00198-022-06619.
PubMed

YU G, Tong S, Liu J, Wan Y, et al
A systematic review of costâ€‘effectiveness analyses of sequential treatment for osteoporosis.
Osteoporos Int. 2022 Dec 17. doi: 10.1007/s00198-022-06626.
PubMed Abstract available

November 2022

GAO SS, Zhao Y
The effects of beta-carotene on osteoporosis: a systematic review and meta-analysis of observational studies.
Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06593.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Fractures is free of charge.